Overweight -> Equal Weight
downgrade
Reason
Morgan Stanley downgraded Absci to Equal Weight from Overweight with a price target of $4.32, down from $5.80. The latest company and pipeline disclosures have meaningfully increased the risk profile and reduced the visibility of near-term, value-accretive execution, contends the analyst, who is updating the firm's valuation and risk framework and, in doing so, lowering its price target and rating.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ABSI
